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ABSTRACT
Objectives We have previously shown that the
cartilage DNA methylome delineates two clusters of
osteoarthritic (OA) hip patients, characterised by
differential methylation of inflammatory genes, while
others have demonstrated a link between zinc
homeostasis and inflammation in OA. We aimed to
investigate these effects at the methylation and gene
expression level.
Methods We used our previously generated
methylation data while quantitative PCR was used to
measure gene expression using RNA from the hip
cartilage of members of both clusters and from control
individuals without hip OA.
Results One of the OA clusters is characterised by the
promoter hypomethylation and increased expression of
inflammation-associated genes including IL1A and TNF.
Furthermore, we show that the increase in expression of
these genes is accompanied by increased expression of
several zinc transporter genes. In addition, the zinc
responsive transcription factor MTF1 is also upregulated,
which is accompanied by an increase in the expression
of its targets the metalloproteinases MMP13 and
ADAMTS5.
Conclusions We have identified a subgroup of OA hip
patients that are epigenetically and transcriptiomically
characterised by a cartilage inflammatory phenotype with
concurrent differential regulation of zinc regulators. The
identification of subgroups enhances stratified
phenotyping of OA patients and has important
implications for future therapeutic applications.
INTRODUCTION
Osteoarthritis is characterised by the focal loss of
articular cartilage at the synovial joints.1 2 Genetic
susceptibility has an established role in osteoarth-
ritic (OA) aetiology, while recent studies have high-
lighted the crucial impact of epigenetics,
specifically DNA CpG methylation, on the disease.3
Initial methylation studies employed a candidate
gene approach, whereas more recent studies have
used powerful genome-wide DNA CpG methyla-
tion arrays to reveal the unique landscape of the
OA cartilage DNA methylome.3–6 These have
reported widespread cartilage methylation changes
between OA and non-OA individuals. Our previous
study revealed subgroups, or clusters, of OA indivi-
duals based on their DNA methylome.5 For the 23
OA hip patients examined in that study, two very
distinct clusters were observed based on the highly
significant differential methylation of inflammation/
immune-related genes.
Although OA has historically been classified as
non-inflammatory, it is now becoming clear that
inflammation plays a role in some patients.7 Much
of the attention on OA inflammation has focused
on the synovium, with the synovial fluid containing
elevated levels of proinflammatory factors.8 Some
studies have suggested a possible role for the chon-
drocyte in inflammation,9 with OA theorised to
result from an unresolved chronic wound healing
response in cartilage that involves the activation of
inflammatory cytokines.10 11 In vitro studies have
also shown that chondrocytes upregulate matrix-
degrading enzymes in response to proinflammatory
factors such as IL-1β, thought to be mediated at
least in part through increased activity of the zinc–
ZIP8–MTF1 axis.11 12 This highlights that zinc
homeostasis is also a key player in OA pathogen-
esis, linking inflammation with cartilage loss.
In our previous study, the 23 OA hip patients
grouped into clusters 1 and 2 containing 11 and 12
patients, respectively, with cluster 2 demonstrating
hypomethylation of the inflammation/immune-
related genes.5 In that report, we had also studied
21 patients who were free of hip OA and had
undergone hip replacement due to a neck of femur
(NOF) fracture. These were more similar to OA
cluster 1 with respect to the methylation of the
inflammation/immune-related genes. In the present
study, we investigated the two OA hip clusters and
the NOF patients in more detail at the DNA
methylation and gene expression level, with a focus
on immune-related genes and zinc homeostasis.
MATERIALS AND METHODS
Patient information is shown in online supplemen-
tary table S1, and a list of the primers used is
shown in online supplementary table S2. A detailed
description of the material and methods can be
found in the online supplementary text.
RESULTS
Inflammatory/immunity genes are demethylated
in a subset of OA hip samples
We used our previously generated methylation data
to search for sites that were significantly differen-
tially methylated between OA hip cluster 2 (12
patients) and both OA hip cluster 1 (11 patients)
and the 21 NOF patients. In total, we identified
10 064 differentially methylated CpG loci, of
which 4308 were hypomethylated and 5756 were
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hypermethylated in OA hip cluster 2 compared with both NOF
and OA hip cluster 1 (see online supplementary tables S3 and
S4). We performed gene ontology term analysis of both hyper-
methylated and hypomethylated genes (see online supplemen-
tary tables S5 and S6). Analysis of the hypomethylated genes
revealed a striking enrichment of terms related to inflammation
and immunity (table 1), matching our previous results where we
had compared just the two OA hip clusters.5
Analysis of the methylation of the promoters of
inflammation-associated genes
Hypomethylation of the inflammation-associated genes predom-
inantly occurred within their promoters. We therefore analysed
the methylation status of the promoters of a group of six
inflammatory-related genes, selected on the basis that they con-
tained at least one differentially methylated probe from our
genome-wide analysis. In this analysis, we also included probes
that were genome-wide significant irrespective of the difference
in methylation. The genes selected coded for factors known to
have a role in OA and were TNF, IL6, IL1A, the IL8 receptor
CXCR2 and the chemokines CCL5 and CCL2. Information
regarding the CpG probes studied for each gene can be found in
online supplementary table S7 (the CpG probes listed as resid-
ing in the gene body are in regions defined by ENCODE (http://
genome.ucsc.edu/ENCODE/) as having promoter activity).
Figure 1 shows that in OA hip cluster 2 these inflammatory-
associated genes undergo promoter demethylation in compari-
son to both OA hip cluster 1 and NOF, the only exception
being one of the four IL6 probes (cg07998387). Promoter
demethylation was accompanied by an increase in expression of
all six genes in OA hip cluster 2 (figure 2). The correlation
between DNA methylation and gene expression is shown in
online supplementary figures S1 and S2, and table S8.
Regulation of zinc transporters in the
inflammation-associated group of individuals
It has been shown that elevated intracellular zinc levels are
involved in the upregulation of metalloproteinases in OA.12
Intriguingly, inflammatory factors such as IL1 are known to
regulate the ZIP group of zinc transporters, including in mouse
articular chondrocytes.13 We initially observed that the zinc
transporter genes ZIP4 (SLC39A4), ZIP7 (SLC39A7), ZIP11
(SLC39A11) and ZIP14 (SLC39A14) were differentially methy-
lated between our two OA hip clusters (see online supplemen-
tary figure S3 and table S9). We therefore investigated whether
the zinc transporter genes were differentially expressed between
the clusters. In the recent report highlighting the role of zinc
homeostasis in OA, IL-1β was revealed to be a pivotal regulator
of ZIP genes.12 13 We therefore specifically investigated its gene
in this context and observed that IL1B is upregulated in OA hip
cluster 2 (figure 3A). The expression of all 14 zinc importers
(ZIP1-14; SLC39A1-14) was then assessed. ZIP1, ZIP2, ZIP5
and ZIP12 were not expressed in hip cartilage (data not shown)
but 6 of the 10 importers that are expressed are upregulated in
cluster 2, with expression correlating positively with methyla-
tion (see figure 3B, online supplementary figure S4 and table
S10). Further to this, the expression of the six ZIP genes corre-
lated positively with the level of expression of proinflammatory
genes and these correlations were consistently significant for
IL1A and TNF (see online supplementary figures 5 and 6 and
table S11). Furthermore, we observed upregulation in cluster 2
of MT1A, MT1G and MT1H, which code for zinc binding
metallothioneins that control intracellular zinc levels (figure
3F–H). In addition, several of the ZnT zinc exporter group of
genes are also upregulated in cluster 2 (figure 3I). This may be
as a consequence of increased intracellular levels of Zn2+ and/or
result from the increased expression of the zinc transporter gene
regulator MTF1 that we observed (figure 3C). Finally,
ADAMTS5 and MMP13, two downstream targets of MTF1, are
also upregulated in cluster 2. (figure 3D, E)
DISCUSSION
In this study, we report on a clear subset of OA hip patients who
undergo demethylation of the promoters of inflammatory/
immunity-related genes. Demethylation is accompanied by
increased expression of inflammatory factors, suggesting that car-
tilage inflammation may play a more integral role in the disease
pathogenesis in this group of individuals. We also show that the
increase in the expression of inflammatory genes correlates with
the expression of zinc transporter and metalloproteinase genes.
Our observations resonate with other complex diseases, where
patients can present with the same disease phenotype but the
underling genetic/epigenetic status differs.14–16
Proinflammatory cytokines such as IL6, IL1 and TNF-α are
known to influence zinc homeostasis through regulating the
expression of zinc transporter genes.17 18 Intriguingly, it has
been shown recently that ZIP8 upregulation induces the expres-
sion of matrix-degrading enzymes in chondrocytes.12 This has
led to the suggestion that zinc regulation could offer therapeutic
opportunities in OA. Our data support this but very clearly
highlight that this may be particularly applicable to a subgroup
of OA individuals; ZIP8 expression demonstrated very signifi-
cant differential expression between the two clusters.
While we see differential methylation of several ZIP genes, it
is not clear whether it is this or whether it is the increase in the
expression of the inflammatory factors that is driving this
Table 1 Example of inflammation/immune-related gene ontology
(GO) terms for genes hypomethylated in osteoarthritic hip cluster 2
GO term
Number
of genes
Bonferroni
p value
Immune system process 198 1.28×10−19
Immune response 306 5.76×10−15
Defence response 128 2.1×10−11
Regulation of immune response 83 1.87×10−09
Innate immune response 87 3.78×10−09
Activation of immune response 45 1.04×10−05
Immune system development 62 1.18×10−05
Lymphocyte activation 32 3.41×10−04
Regulation of leucocyte activation 43 5.58×10−04
Positive regulation of T cell activation 27 5.91×10−04
Regulation of defence response 52 1.06×10−03
Regulation of IL-1β production 11 2.35×10−03
Regulation of cytokine production 48 3.14×10−03
Positive regulation of leucocyte-mediated
immunity
15 1.01×10−02
Regulation of T cell activation 30 1.11×10−02
Leucocyte differentiation 21 1.13×10−02
T cell co-stimulation 14 1.26×10−02
Response to interferon-gamma 18 1.44×10−02
Lymphocyte co-stimulation 14 1.48×10−02
Regulation of lymphocyte-mediated immunity 16 2.69×10−02
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Figure 1 The promoters of inflammatory genes are demethylated in a subgroup of osteoarthritic (OA) hip patients. The level of methylation is
shown as the β value obtained from the HumanMethylation450 BeadChip array for a total of 21 neck of femur (NOF) patients, 11 OA hip cluster 1
patients and 12 OA hip cluster 2 patients. The methylation levels are shown for six inflammation-associated genes; (A) TNF; (B) CXCR2; (C) CCL2;
(D) IL6; (E) CCL5; (F) IL1A. Data are shown as the mean and the standard error of the mean and statistical analysis was performed by one-way
analysis of variance with the Tukey test. ***p<0.001, **p<0.01, *p<0.05.
Figure 2 Demethylation of the
promoter is accompanied by an
increase in the expression of
inflammation-associated genes. Gene
expression was measured in five neck
of femur (NOF), five osteoarthritic (OA)
hip cluster 1 and six OA hip cluster 2
patients who had all been included in
the original methylation analysis. Data
are presented as 2−ΔΔCt with the NOF
data serving as the control group and
are shown as the mean and the
standard error of the mean. Statistical
analysis was performed by one-way
analysis of variance with the Tukey
test. ***p<0.001, **p<0.01, *p<0.05.
Gene expression was measured in the
six previously identified differentially
methylated genes; (A) TNF; (B) CXCR2;
(C) CCL2; (D) IL6; (E) CCL5; (F) IL1A.
Rushton MD, et al. Ann Rheum Dis 2015;0:1–5. doi:10.1136/annrheumdis-2014-206752 3
Basic and translational research
group.bmj.com on May 6, 2015 - Published by http://ard.bmj.com/Downloaded from 
increase. It may be that the inflammatory genes regulate ZIP
gene expression via DNA methylation.
The expression correlations that we have observed between
inflammatory and zinc genes are very noteworthy, but clearly
the expression of other genes may also correlate. A more com-
prehensive analysis is therefore called for.
In this study, we focused on the inflammatory subgroups that
are present within OA hip samples. Subgroups have been
observed in OA knee samples, but the clustering is much more
heterogeneous than that in OA hip.5 For this reason, we focused
our study on OA hip. However, we cannot rule out that the
inflammatory and zinc gene effects reported in this study occur
in OA knee. A similar study in OA knee is therefore warranted.
In conclusion, we show that the cartilage methylome identi-
fies an inflammatory-associated subgroup of OA hip individuals
with concurrent differential regulation of zinc regulators. The
identification of subgroups of patients has important implica-
tions for the testing and application of disease-modifying OA
therapeutics, with disease interventions needing to be tailored
to the underlying genetic/epigenetic profile of an individual.
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